Stay updated on Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added related topics to the page: Lung cancer and MedlinePlus Genetics. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2025-11-03T01:13:33.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    31 days ago
    Change Detected
    Summary
    - Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.
    Difference
    4%
    Check dated 2025-10-05T10:11:50.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-28T03:13:50.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    - The page now removes MedlinePlus Genetics coverage related to Lung cancer, narrowing the topic scope without adding new content.
    Difference
    0.3%
    Check dated 2025-09-20T22:04:45.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Adds Lung cancer topic under MedlinePlus Genetics and updates to v3.0.2; removes the Back to Top element and the old v3.0.1 revision.
    Difference
    0.5%
    Check dated 2025-09-13T16:59:36.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-06T14:31:43.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial page.